Cover Image

Surfactant therapy for acute respiratory distress in infants

Acute respiratory distress syndrome (ARDS) remains the primary indication for admission to paediatric intensive care units and accounts for significant mortality, morbidity and resource utilization. Respiratory infections, in particular pneumonia and severe bronchiolitis, are the most common causes...

Full description

Saved in:

Bibliographic Details
Main Authors:	Corrado Moretti (Author), Caterina S. Barbàra (Author), Rosanna Grossi (Author), Stefano Luciani (Author), Fabio Midulla (Author), Paola Papoff (Author)
Format:	Book
Published:	Hygeia Press di Corridori Marinella, 2014-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
by: Mandy Brasher, et al.
Published: (2021)

Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome
by: Xing-An Wang, et al.
Published: (2020)

FiO2 Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
by: Piotr Kruczek, et al.
Published: (2021)

Treatment of acute respiratory distress syndrome in secondary surfactant deficiency in neonates
by: Heru Samudro, et al.
Published: (2016)

Comparison of Respiratory Outcomes between Less Invasive Surfactant Administration and the Intubation-Surfactant-Extubation Technique in Premature Infants with Respiratory Distress Syndrome
by: Hye Seon Kim, et al.
Published: (2020)

Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
by: Heui Seung Jo
Published: (2019)

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
by: Ga Won Jeon
Published: (2019)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
by: Shengguang Wang, et al.
Published: (2021)

Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial
by: Mohammad Kazem Sabzehei, et al.
Published: (2022)

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
by: Ji Won Koh, et al.
Published: (2018)

Surfactant Therapy for Respiratory Distress Syndrome in High- and Ultra-High-Altitude Settings
by: Xudong Duan, et al.
Published: (2022)

Flow-synchronized nasal intermittent positive pressure ventilation in the preterm infant: development of a project
by: Corrado Moretti, et al.
Published: (2013)

Early versus late extubation after surfactant replacement therapy for respiratory distress syndrome
by: Mohamed Garib, et al.
Published: (2015)

A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study
by: Andrea Wolfler, et al.
Published: (2019)

Diagnostic utility of lung ultrasound in predicting the need for surfactant therapy in preterm neonates with respiratory distress
by: Pari Singh, et al.
Published: (2023)

Single Nucleotide Polymorphisms Interactions of the Surfactant Protein Genes Associated With Respiratory Distress Syndrome Susceptibility in Preterm Infants
by: Shaili Amatya, et al.
Published: (2021)

Corrigendum: Single nucleotide polymorphisms interactions of the surfactant protein genes associated with respiratory distress syndrome susceptibility in preterm infants
by: Shaili Amatya, et al.
Published: (2022)

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
by: Majid Mohammadizadeh, et al.
Published: (2015)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
by: Anna Tarocco, et al.
Published: (2015)

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress
by: Mehmet Yalaz, et al.
Published: (2022)

Genetic surfactant dysfunction in newborn infants and children with acute and chronic lung disease
by: Marco Somaschini, et al.
Published: (2017)

Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant
by: van Zyl JM, et al.
Published: (2013)

Tension pneumopericardium in an infant with acute respiratory distress syndrome
by: Marc Tesnière, et al.
Published: (2020)

Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
by: Jing Liu, et al.
Published: (2022)

Corrigendum to "Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress"
by: Anna Tarocco, et al.
Published: (2015)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
by: Frans J. Walther, et al.
Published: (2022)

Comparison of the Efficacy of Three Natural Surfactants in Preterm Turkish Newborns with Respiratory Distress Syndrome
by: Fatma Hilal Yılmaz, et al.
Published: (2021)

Surfactant therapy in late preterm infants
by: Murat Yurdakök
Published: (2013)

Alternative therapies for respiratory distress syndrome in preterm infants
by: Sinha IP, et al.
Published: (2011)

A multicentre neonatal interventional randomised controlled trial of nebulized surfactant for preterm infants with respiratory distress: Neo-INSPIRe trial protocol
by: Ilse Lategan, et al.
Published: (2023)

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
by: J Wells Logan, et al.
Published: (2009)

The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial
by: Asghar Marzban, et al.
Published: (2024)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
by: Silvia Mikolajcikova, et al.
Published: (2022)

Outcome of Very Premature Newborn Receiving an Early Second Dose of Surfactant for Persistent Respiratory Distress Syndrome
by: Eva Greiner, et al.
Published: (2021)

An unusual cause of respiratory distress in an infant
by: Pragati A Sathe, et al.
Published: (2020)

Electroencephalogram and magnetic resonance imaging comparison as a predicting factor for neurodevelopmental outcome in hypoxic ischemic encephalopathy infant treated with hypothermia
by: Francesca Del Balzo, et al.
Published: (2014)

Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates
by: Fatemeh Sabzevari, et al.
Published: (2023)

EXOGENOUS SURFACTANTS OF NATURAL ORIGIN IN THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME - COMPARATIVE COMPOSITION, BIOPHYSICAL PROPERTIES AND CLINICAL EFFECTIVENESS
by: D.О. Dobryanskyy
Published: (2020)

Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
by: Tongyan Han, et al.
Published: (2020)

The role of respiratory function tests in infants with stridor: diagnosis at glance and follow-up
by: Silvia Bloise, et al.
Published: (2024)